Inhibitors of the arachidonic acid pathway and peroxisome proliferator–activated receptor ligands have superadditive effects on lung cancer growth inhibition I Avis, A Martínez, J Tauler, E Zudaire, A Mayburd, R Abu-Ghazaleh, ... Cancer Research 65 (10), 4181-4190, 2005 | 138 | 2005 |
Ingenuity network-assisted transcription profiling: Identification of a new pharmacologic mechanism for MK886 AL Mayburd, A Martlinez, D Sackett, H Liu, J Shih, J Tauler, I Avis, ... Clinical cancer research 12 (6), 1820-1827, 2006 | 102 | 2006 |
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets AL Mayburd, I Golovchikova, JL Mulshine Bioinformatics 24 (3), 389-395, 2008 | 15 | 2008 |
Expression variation: its relevance to emergence of chronic disease and to therapy AL Mayburd PLoS One 4 (6), e5921, 2009 | 11 | 2009 |
Increased lifespan, decreased mortality, and delayed cognitive decline in osteoarthritis AL Mayburd, A Baranova Scientific Reports 9 (1), 18639, 2019 | 10 | 2019 |
Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease A Mayburd, A Baranova BMC systems biology 7, 1-18, 2013 | 8 | 2013 |
A public-private partnership for the express development of antiviral leads: a perspective view A Mayburd Expert opinion on drug discovery 16 (1), 23-38, 2021 | 7 | 2021 |
Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy AL Mayburd, M Koivogui, A Baranova Plos one 14 (11), e0224315, 2019 | 6 | 2019 |
Influenza Antiviral Therapeutics (Supplementry Material) AL Mayburd Recent patents on anti-infective drug discovery 5 (1), 64-75, 2010 | 5 | 2010 |
Knowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms for a Complex Disease A Mayburd, A Baranova Biological Networks and Pathway Analysis, 425-461, 2017 | 1 | 2017 |
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral … A Mayburd Expert Review of Anti-infective Therapy 20 (4), 507-511, 2022 | | 2022 |
Predicting High-Impact Pharmacological Targets by Integrating Transcriptome and Text-Mining Features A Mayburd, A Baranova Journal of Pharmacy & Pharmaceutical Sciences 19 (4), 475-495, 2016 | | 2016 |
A possibility of miniaturized fusion and fission hybrid reaction core with positive fusion yield A Mayburd Nuclear engineering and design 241 (1), 59-66, 2011 | | 2011 |